Pharmaceutical company Galderma has revealed results from its two phase IIIb trials investigating relabotulinumtoxinA for the treatment of glabellar lines and lateral canthal lines. The first phase IIIb, randomised, double-blind,
Global aesthetic manufacturer Teoxane has been granted Medical Device Regulation (MDR) certification for two of its injectable products. The company has become the first to manufacture sterile, injectable, hyaluronic acid-based
The Joint Council for Cosmetic Practitioners (JCCP) has formallyapproved the University of Manchester as a new education andtraining provider. The approval is for the University’s Post Graduate Diploma/MSc in SkinAgeing
HA-Derma, the exclusive distributor and training provider for IBSA Derma in the UK and Ireland, invited a select group of practitioners for a two-day masterclass in Milan, Italy. Practitioners included
Aesthetic practitioner Professor Bob Khanna hosted the annual International Academy of Advanced Facial Aesthetics (IAAFA) Conference and Charity Ball on November 25 at the De Vere Beaumont Estate, Windsor, raising